Kostas Tzelepis awarded John Goldman Fellowship

Kostas Tzelepis awarded John Goldman Fellowship

We are delighted to announce that Academic in Residence Kostas Tzelepis has been awarded a John Goldman Fellowship from Leukaemia UK to develop and characterize new drugs against the RNA methyltransferase METTL3, which he has previously uncovered as a relevant...
Kathryn Lilley awarded EMBO membership

Kathryn Lilley awarded EMBO membership

We are delighted to announce that Kathryn Lilley, Director of the Cambridge Centre for Proteomics, is among 63 leading scientists who have been awarded EMBO membership today – elected on the basis of their scientific excellence and pioneering research.  “The new...
Start Codon announces first cohort of companies

Start Codon announces first cohort of companies

Start Codon, the new healthcare accelerator based in the Milner Therapeutics Institute, today announced the first cohort of four companies who were enrolled in the programme this February and will debut at the Milner Symposium event this Friday June 26th and ONHelix...
Eisai join Milner Therapeutics Consortium

Eisai join Milner Therapeutics Consortium

We are delighted to announce that Eisai have joined the Milner Therapeutics Consortium, which now includes 8 pharma partners. Eisai is a leading global research and development-based pharmaceutical company headquartered in Japan. Eisai’s corporate mission is defined...
Milner Institute illuminated blue for the NHS

Milner Institute illuminated blue for the NHS

The Jeffrey Cheah Biomedical Centre illuminated blue tonight, to honour the incredible work of our NHS. Milner Institute Director Professor Tony Kouzarides said “On behalf of scientists in Cambridge and throughout the UK, we thank NHS staff for their selfless...
Milner seminars move online

Milner seminars move online

We have been busy adapting plans for the coming months, and are pleased to announce that our Milner seminars are moving online. The first talk is from Mathew Garnett, and we hope you will join us online for this!  Dr Mathew Garnett (Wellcome Sanger Institute)...

Pin It on Pinterest